Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Rocket Lab USA Inc (RKLB) vs Synopsys, Inc. (SNPS) Price & Performance

Rocket Lab USA IncTrade
Synopsys, Inc.Trade

Price performance (Past 24H)

Key statistics

Rocket Lab USA Inc vs Synopsys, Inc. — how do they compare? Rocket Lab USA Inc trades at $68.21 (market cap $43.74B), while Synopsys, Inc. trades at $509.99 (market cap $95.39B). The key difference: Synopsys, Inc. is far larger — about 2.2× Rocket Lab USA Inc's market cap, and Synopsys, Inc. is trading nearer its 52-week high, Rocket Lab USA Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rocket Lab USA Inc for 29 Days and Synopsys, Inc. for 71 Days on average.

RKLBSNPS
Market Cap
$43.74B$95.39B
Volume
22,892,5813,374,903
Sector
IndustrialsTechnology
52-Week High
$150.23$534.56
52-Week Low
$39.48$367.70
Typical Hold Time
29 Days71 Days
Enterprise Value
$41.57B$102.62B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Rocket Lab USA Inc

Rocket Lab (RKLB) trades at $68.40, down 4.89% amid a bearish technical signal. The company shows strong revenue growth with $602M in 2025 and $769M projected for 2026, though it remains unprofitable with a -21.51% net margin. Recent positive developments include securing its largest-ever commercial Electron launch contract with Synspective, expanding the backlog to over 100 missions. Analyst sentiment remains bullish with a $107 consensus price target despite current losses.

The outlook balances significant growth potential against persistent profitability challenges. Investment opportunity lies in Rocket Lab's expanding launch backlog and market position, while risks include intense competition from SpaceX, high valuation multiples, and ongoing cash burn. The stock's current technical weakness contrasts with strong fundamental growth prospects and Wall Street optimism.

Synopsys, Inc.

Synopsys (SNPS) trades at $497.75, down 0.98% on the day, but maintains a strong bullish technical trend with support at $492. The company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of $3.91 exceeding the $3.67 estimate. Recent investor day announcements highlighted AI partnerships with OpenAI and Amazon, driving a 13% stock surge and raising long-term growth expectations. Valuation metrics show a high P/E of 86.87, reflecting premium pricing for growth prospects.

The outlook for SNPS is positive, fueled by AI-driven demand for chip design software and strategic acquisitions like Ansys. Investment opportunities include exposure to the expanding custom silicon market and recurring revenue growth. Key risks involve elevated valuation multiples, integration challenges from acquisitions, and competitive pressures in the EDA software space. Analyst consensus is strongly bullish with a $572.54 price target, indicating 15% upside potential.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RKLB
92% Buy8% Sell
Avg holding period · 29 Days
SNPS
33% Buy67% Sell
Avg holding period · 71 Days

Top news

Latest headlines on both assets

About Rocket Lab USA Inc

Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.

Read more on RKLB →

About Synopsys, Inc.

Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Read more on SNPS →